A “Symbiter” containing 14 live probiotic strains of Acetobacter, Propionibacterium, Bifidobacterium, and Lactobacillus + Lactococcus improved tumor necrosis factor (TNF)-α, IL6, aminotransferase activity, and hepatic steatosis in NAFLD patients [86]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.